跳转至内容
Merck
CN
  • Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation.

Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation.

Acta biomaterialia (2017-01-31)
Furqan A Maulvi, Anjum A Shaikh, Dhara H Lakdawala, Ankita R Desai, Mihir M Pandya, Sulabh S Singhania, Rutvi J Vaidya, Ketan M Ranch, Bhavin A Vyas, Dinesh O Shah
摘要

Contact lenses are widely used for ophthalmic drug delivery, but incorporation of drug or formulation in the contact lenses affects its optical and physical property. In the present study, we have designed a novel hyaluronic acid (HA)-laden ring implant contact lenses (modified cast moulding method), to circumvent the changes in critical lens property. The objective was to improve the ocular residence time of HA, by providing sustained ocular HA delivery through implant contact lenses for the treatment of dry eye syndrome. Optimization of HA-implant was carried out using 3 The limitation of contact lenses to be used as therapeutic device for controlled drug delivery is focused in this study. Incorporation of drug or formulation in the biomaterial affects the optical and physical property of contact lenses. The significance of project was to design a novel hyaluronic acid-laden ring implant contact lenses, to by-pass the changes in critical property of biomaterial.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
乙二醇二甲基丙烯酸酯, 98%, contains 90-110 ppm monomethyl ether hydroquinone as inhibitor